Page last updated: 2024-08-23

epirubicin and Lung Neoplasms

epirubicin has been researched along with Lung Neoplasms in 267 studies

Research

Studies (267)

Timeframe	Studies, this research(%)	All Research%
pre-1990	26 (9.74)	18.7374
1990's	115 (43.07)	18.2507
2000's	79 (29.59)	29.6817
2010's	36 (13.48)	24.3611
2020's	11 (4.12)	2.80

Authors

Authors	Studies
Jiang, X; Li, M; Ma, ST; Miao, L; Wang, YM; Zhang, HH	1
Akash, S; Alhumaydhi, FA; Emran, TB; Idris, AM; Khandaker, MU; Kim, B; Kumer, A; Park, MN; Rahman, MM; Sharma, R; Singla, RK; Wilairatana, P	1
Altuntas, S	1
Mesén-Porras, S; Molina-Mora, JA; Mora-Rodríguez, R; Quiros, S; Rojas-Céspedes, A; Siles, F; Vega-Baudrit, J	1
Cai, FY; Fu, M; He, SY; Jing, M; Ju, RJ; Kong, L; Li, XT; Liu, JJ; Liu, XZ; Yao, XM; Zhang, L	1
Baker, J; Dexter, PR; He, J; Hui, SL; Jin, F; Kachroo, S; Shao, C; Zhang, Z	1
Bornschein, J; Evert, M; Herr, W; Munker, S; Schlitt, H; Stroszczynski, C; Teufel, A; Vogelhuber, M	1
Bi, XJ; Cai, F; Fu, M; He, SY; Jia, LQ; Jing, M; Kong, L; Li, XT; Liu, JJ; Liu, XZ; Yao, XM; Zhang, L	1
Akashi, H; Ando, K; Furuya, D; Kawada, H; Kawai, H; Ogawa, Y; Suzuki, R	1
Bahkali, AH; Gupta, N; Kumari, RM; Nimesh, S; Sharma, N; Syed, A	1
Hou, E; Lai, L; Lu, Y; Meng, W; Tan, Z; Wei, J; Zhang, X	1
Funakoshi, T; Hirai, I	1
Hori, A; Hori, S; Kennoki, N; Yuki, T	1
An, L; Chu, HX; Fan, YH; Feng, F; Li, DD; Ma, HD; Song, Q; Wang, CL; Zhang, Q; Zhao, QC	1
Cheng, L; Fu, M; Gu, LY; Ju, RJ; Li, XT; Liu, JJ; Liu, S; Song, XL; Wang, X; Xiao, Y	1
Fan, J; Qiao, B; Zhang, W	1
Davies, H; Jiang, L; Shi, K; Xu, X	1
Cai, FY; Fu, M; Gong, XQ; Jing, M; Ju, RJ; Kong, L; Li, XT; Liu, JJ; Tang, W; Yao, XM	1
Evangelatov, A; Skrobanska, R; Yordanov, G	1
Abdeen, S; Alexander, P; Bhagat, M; Chavali, M; Praseetha, PK; Rose, PA	1
Adams, S; Esener, S; Hayashi, T; Ibsen, S; Norton, J; Su, Y; Wrasidlo, W; Zahavy, E	1
Bakalos, G; Doxani, C; Miligkos, M; Mpoulimari, I; Rodopoulou, P; Zintzaras, E	1
Boukovinas, I; Christophyllakis, C; Georgoulias, V; Kakolyris, S; Malamos, N; Mavroudis, D; Papakotoulas, P; Politaki, E; Polyzos, A; Tryfonidis, K; Xenidis, N	1
Chi, Y; Song, Y; Wang, J; Yang, L; Zhou, A	1
Cao, J; Guo, W; Huang, M; Ji, D; Li, J; Liu, X; Peng, W; Sun, S; Wang, C; Yin, J; Yu, H; Zhao, X; Zhu, X	1
Basso, U; Maruzzo, M; Montesco, MC; Rastrelli, M; Roma, A; Zanardi, E	1
Gao, QG; Li, B; Li, W; Qin, ZH; Wu, HR; Xie, JM; Yu, HP	1
Fan, HX; Fang, H; Huang, H; Li, XS; Song, YL; Zhou, CW	1
Fujii, T; Ikeda, T; Kimura, H; Nakayama, H; Sakai, Y	1
Barlesi, F; Barre, P; Chatellain, P; Dayen, C; Derollez, M; Fournel, P; Herman, D; Jeannin, G; Lamy, PJ; Langlais, A; Lavole, A; Le Caer, H; Molinier, O; Morin, F; Moro-Sibilot, D; Mourlanette, P; Oster, JP; Pujol, JL; Quoix, E; Renault, A; Souquet, PJ; Zalcman, G	1
Bi, J; Cao, B; Chen, L; Dai, H; Deng, Y; Hu, J; Jia, L; Jiang, H; Li, W; Meng, C; Nan, K; Shen, K; Shen, P; Shi, J; Song, Y; Sun, Q; Sun, Y; Tang, L; Tian, F; Tong, Z; Wang, S; Wu, G; Wu, Q; Wu, Y; Xie, X; Xu, B; Yu, J; Yuan, Z; Yue, S; Zhang, B; Zhang, Q; Zhang, Y; Zhuang, W	1
Hou, H; Li, T; Liu, C; Liu, D; Liu, K; Lv, H; Wang, G; Zhang, C; Zhang, X; Zhou, N; Zhu, J	1
Becerra, CR; Frenkel, EP; Tavana, D; Tran, HT; Verma, UN; Williams, NS	1
Davies, A; Gandara, D; Huynh, M; Johl, J; Lara, P; Lau, D; Tanaka, M	1
Artal-Cortes, A; Barneto, I; Camps, C; Carrato, A; Gómez-Codina, J; González-Larriba, JL; Isla, D; Rosell, R; Safont, MJ; Sirera, R	1
Bae, SH; Choi, IB; Choi, JY; Han, CW; Jang, JW; Jung, HS; Kay, CS; Kim, CW; Yoon, SK; You, CR	1
Funada, T; Kaiga, T; Kochi, M; Mamiya, T; Ohkubo, R; Takayama, T; Yoshida, N	1
Chang, JW; Chen, CH; Lin, CM; Tsao, TC	1
Bearz, A; Berretta, M; Canzonieri, V; Ciancia, EM; Gobitti, C; Martellotta, F; Pavone, P; Taibi, R; Tirelli, U; Zanet, E	1
Berry, H; Dodwell, DJ; Gillibrand, A; Kumar, S; Perren, TJ; Velikova, G; Waters, SH	1
Ishiguro, K; Nishimura, M; Suda, T; Uchida, N	1
Hanai, K; Hongoh, S; Inatsuchi, H; Kawakami, M; Nomoto, T; Terachi, T	1
Chen, JM; Chen, Y; Gong, GQ; Liu, QX; Luo, JJ; Qian, S; Wang, JH; Wang, XL; Yan, ZP	1
de Vries, EG; Groen, HJ; Maring, JG; Maurer, M; Uges, DR; Wachters, FM	1
Bruneton, D; Cassier, PA; Chayvialle, JA; Hervieu, V; Lombard-Bohas, C; Pilleul, F; Scoazec, JY; Walter, T	1
Contreras Ibáñez, JA; Díaz Gómez, L; Navas García, N	1
Cegovnik, U; Kern, I; Korošec, P; Košnik, M; Rijavec, M; Silar, M; Triller, N	1
Chen, Y; Li, H; Liu, DZ; Yan, D; Zeng, HY; Zhou, CW	1
Blijham, GH; Erdkamp, FL; Knibbeler-van Rossum, CT; Lalisang, RI; Loosveld, OJ; Nortier, JW; Rodenburg, CJ; Schouten, HC; Slee, PH; Smals, AE; Tjan-Heijnen, VC; van Bochove, A; Voest, EE; Wals, J; Wils, JA	1
Bozonnat, MC; Chakra, M; Gervais, R; Jacot, W; Molinier, O; Pujol, JL; Quantin, X	1
Guan, QL; Jiang, L; Mi, DH; Wang, J; Yang, KH	1
Cufer, T; Kern, I; Knez, L; Košnik, M; Ovčariček, T; Sadikov, A; Sodja, E	1
Dong, XJ; Li, LY; Wang, MZ; Xia, Y; Zhang, L; Zhang, XT; Zhao, J; Zhong, W	1
Cufer, T; Kern, I; Knez, L; Ovčariček, T; Sadikov, A; Sodja, E	1
Abotouk, N; Halim, A	1
Hassali, MA; Hassan, BA; Othman, SB; Weiderpass, E; Yusoff, ZB	1
Chiu, HC; Chu, CY; Yang, CH	1
Alessandroni, P; Catalano, G; Catalano, V; Fedeli, A; Giordani, P; Graziano, F; Luzi Fedeli, S; Rossi, D; Testa, E	1
Basolo, F; Bottici, V; Elisei, R; Mazzeo, S; Montanelli, L; Pacini, F; Pinchera, A; Santini, F	1
Andreesen, R; Bodenstein, H; Clemens, M; Fehnle, K; Fischer, JT; Heidemann, E; Hirschmann, WD; Kaufmann, M; König, M; Mahlke, M; Oberhoff, C; Scharl, A; Schulze, M; Souchon, R; Stoeger, H	1
Johnson, DH	1
Aamdal, S; Aasebø, U; Boye, N; Bremnes, RM; Dahle, R; Hannisdal, E; Hatlevoll, R; Kaasa, S; Skovlund, E; Sundstrøm, S; Vigander, T; Vilsvik, J; Wang, M	1
Xiao, QM; Zhang, WD; Zhou, JH	1
Amdur, RJ; Hinerman, RW; Mendenhall, WM; Monroe, AT; Morris, CG	1
Erturk, D; Unsal, M	1
Fujimura, Y; Miyayama, H; Nagao, K; Nakagawa, K; Nishimura, R; Okazaki, S	1
Bighin, C; Del Mastro, L; Lunardi, G; Schettini, G; Stevani, I; Vannozzi, MO; Venturini, M	1
Boezen, HM; de Leede, GP; de Vries, EG; Eppinga, P; Erjavec, Z; Groen, HJ; Kramer, H; Strijbos, JH; Van Putten, JW; Wachters, FM	1
Crucitta, E; De Lena, M; Fiore, M; Lorusso, V; Piscitelli, D; Silvestris, N	1
Blouin, P; Branchereau, S; Brugières, L; De Kraker, J; Leverger, G; Rubie, H; Tabone, MD	1
Altinbas, M; Cetin, M; Coskun, HS; Er, O; Eser, B; Ozkan, M; Soyuer, S; Unal, A	1
Alonso, C; Arrivi, A; Artal-Cortés, A; Barneto, I; Campbell, J; Camps, C; Carrato, A; Font, A; Garcia-Giron, C; Gomez-Codina, J; Gonzalez-Larriba, JL; Isla, D; Lomas, M; Maestu, I; Meana, A; Rosell, R; Vadell, C	1
Cai, HY; Cao, HP; Dong, XC; Liu, XD; Wang, XQ; Zhang, ZY	1
Aamdal, S; Aasebø, U; Bremnes, RM; Kaasa, S; Sundstrøm, S	1
Fukami, Y; Hasegawa, H; Hiromatsu, T; Itazu, K; Kawai, K; Komatsu, S; Sakamoto, E; Tabata, T	1
Fantini, M; Fattori, PP; Fochessati, F; Genestreti, G; Imola, M; Ioli, G; Lazzari-Agli, L; Mianulli, AM; Papi, M; Pasquini, E; Poggi, B; Ravaioli, A; Sartori, S; Tamburini, E; Tassinari, D	1
Andersen, PK; Dombernowsky, P; Nielsen, D; Osterlind, K; Ryberg, M; Skovsgaard, T	1
Agostini, V; Arcangeli, V; Fantini, M; Fattori, PP; Fochessati, F; Genestreti, G; Imola, M; Ioli, G; Mianulli, AM; Oliverio, G; Papi, M; Pasquini, E; Poggi, B; Ravaioli, A; Tamburini, E; Tassinari, D	1
Brunetti, C; Carreca, I; Comella, G; Comella, P; D'Aiuto, M; D'Aniello, R; DeCataldis, G; Frasci, G; Giordano, R; Muci, D; Palmeri, S; Russo, A	1
Chen, MC; Cheng, AL; Hsu, CH; Whang-Peng, J; Yang, CH; Yang, PC; Yeh, KH; Yu, YC	1
Lui, J; Xu, S; Yang, W	1
Basić, I; Orsolić, N	1
Bighin, C; Cappuzzo, F; Del Mastro, L; Durando, A; Lambiase, A; Monfardini, S; Nicoletto, O; Olmeo, N; Puglisi, F; Venturini, M	1
Barlesi, F; Daurès, JP; Pujol, JL	1
Almeida, MT; Alves, MT; Borsato, ML; Brunetto, AL; Bruniera, P; Camargo, OP; Consentino, E; Davi, A; de Camargo, B; dos Santos, TM; Filho, VO; Jesus-Garcia, R; Macedo, CR; Mendes, WL; Oliveira, CR; Ortega, J; Pena, W; Péricles, P; Petrilli, AS; Prospero, JD	1
Bisogno, G; Casale, F; Cecchetto, G; De Salvo, G; Di Martino, M; Di Tullio, MT; Donfrancesco, A; Donofrio, V; Ferrari, A; Indolfi, P; Martone, A	1
Baldini, E; Conte, PF; Del Freo, A; Fabbri, A; Falcone, A; Innocenti, F; Pennucci, MC; Prochilo, T; Russo, F; Tibaldi, C	1
Budman, DR; Calabro, A	1
Battiloro, C; Caponigro, F; Danilo, R; Formato, R; Iaffaioli, RV; Illiano, A; Tortoriello, A	1
Bolgova, LS; Klapchuk, AG; Rodzaevskiĭ, SA; Tuganova, TN	1
Guo, W; Qiu, WL; Yu, Y; Zhou, XJ	1
Chen, YX; Jiang, GM; Tian, F; Zhao, JW	1
Chen, Z; Cheng, WW; Jiang, GL; Lin, JH; Liu, LM; Meng, ZQ; Zhang, XJ; Zhou, ZH	1
Biesma, B; Bolhuis, RJ; Paul, MA; Phernambucq, EC; Postmus, PE; Schramel, FM; Smit, EF; vd Tol, A	1
Karakuzu, A; Koc, M; Ozdemir, S	1
Giommoni, E; Grifoni, R; Mercatelli, A; Neri, B; Pantaleo, P; Pantalone, D; Paoletti, C; Rotella, V; Taddei, A; Tonelli, P	1
Li, DP; Liu, YL; Song, XR; Wang, XW; Wei, L	1
Baruch, NB; Biran, H; Dinerman, M; Idelevich, E; Karminsky, N; Katsenelson, RL; Man, S; Shani, A; Zvi, NB	1
Chang, LC; Kuo, KW; Liang, CH; Sheu, HM; Shiu, LY	1
Argnani, M; Ciucci, G; De Giorgi, U; Kopf, B; Marangolo, M; Minzi, C; Rosti, G	1
Brock, CS; Eccles, S; Francis, N; Lim, A; McLean, SR; Nathan, M; Palmieri, C; Shousha, S	1
Couban, S; Crump, M; Dancey, J; Girouard, C; Gluck, S; Kirkbride, P; Levine, M; Marlin, S; O'Reilly, S; Pritchard, KI; Shepherd, L; Shore, T; Stewart, D; Tu, D	1
Chang, LC; Kuo, KW; Liang, CH; Sheu, HM; Shiu, LY; Tsai, EM	1
Alvarez, A; Dirix, L; Dumez, H; Latz, J; Melemed, A; Oliveira, CT; Paridaens, R; Prové, A; Simms, L; Wildiers, H	1
Cheng, AL; Hsu, C; Hu, FC; Huang, TC; Kuo, SH; Lin, CC; Shih, JY; Yang, CH; Yang, PC; Yu, CJ	1
Hansen, HH; Hansen, M; Joss, RA; Renard, J; Rozencweig, M	1
Casper, ES; Gralla, RJ; Heelan, RT; Kalman, LA; Kelsen, DP; Kris, MG; Wittes, RE	1
Farabegoli, G; Ganzina, F; Giovannini, M; Martoni, A; Monetti, N; Pannuti, F; Tomasi, L	1
Grunenberg, B; Krischke, W; Niederle, N; Schmidt, CG; Schütte, J; Seeber, S	1
Adachi, K; Horikoshi, N; Ikeda, K; Inagaki, J; Inoue, K; Nakada, K; Ogawa, M; Okada, Y; Tada, A; Usui, N	1
Berenson, RJ; Brugger, W; Heimfeld, S; Henschler, R; Kanz, L; Mertelsmann, R	1
Abad, A; Ariza, A; Barnadas, A; Carles, J; Fernandez-Vasalo, G; Pellicer, I; Rosell, R; Sanchez, JJ	1
Igawa, M; Kadena, H; Ueda, M; Usui, T	1
Brugger, W; Frommhold, H; Kanz, L; Mertelsmann, R; Pressler, K	1
Akiyama, J; Hyogo, H; Ito, K; Kida, M; Kido, S; Kojima, K; Matsuda, M; Matsuura, M; Nakajima, N; Yamamoto, K	1
Nabeyama, A; Nakajima, A; Nakao, A; Okada, Y; Sakagami, K; Sato, S	1
Behnam Motlagh, P; Grankvist, K; Henriksson, R	1
Airoma, G; Bianco, AR; De Placido, S; Gridelli, C; Incoronato, P; Palazzolo, G; Pepe, R; Rossi, A	1
Babiĭ, IaS; Bolgova, LS; Galakhin, KA; Iugrinov, OG; Klapchuk, AG; Pozmogov, AI; Rodzaevskiĭ, SA; Tuganova, TN	1
Adamo, C; Angeletti, CA; Chella, A; Dini, P; Mussi, A; Ribechini, A	1
Hosaka, M; Kubota, Y; Masuda, M; Noguchi, S; Oouchi, H; Shuin, T	1
Grankvist, K; Henriksson, R; Motlagh, PB	1
Fukunishi, H; Kitazawa, S; Takeuchi, S; Yukimura, N	1
Jassem, E; Jassem, J; Karnicka-Młodkowska, H; Malak, S; Moś-Antkowiak, R; Pilarska-Machowicz, A; Szymaczek-Meyer, L; Słupek, A; Wiatr, E; Zych, J	1
Cartei, G; Crivellari, D; Della Valentina, M; Foladore, S; Magri, MD; Nascimben, O; Sibau, A; Talamini, R; Trovò, MG; Veronesi, A	1
Berchier, MC; Bureau, G; Giner, V; Kroll, F; Küstner, U; Michel, J; Mommen, P; Sculier, JP; Thiriaux, J; Van Cutsem, O	1
Atikachi, B; Jiemsripong, K; Phromwas, N; Thongprasert, S	1
Abe, R; Hatakeyama, Y; Hoshino, M; Igarashi, W; Koyama, Y; Ohtake, T; Ono, T; Sato, N	1
Kikkawa, N; Kobayashi, K; Mishima, H; Nakagawa, H; Shin, E; Takatsuka, Y; Tamaki, Y; Tono, T; Yagyu, T	1
Jiamsriponges, K; Thongprasert, S	1
de Jonge, A; Karim, AB; Meyer, OW; Njo, KH; Slotman, BJ	1
Brancaccio, L; Comella, G; Curcio, C; D'Aprile, M; Ferrante, G; Gentile, M; Gridelli, C; Palmeri, S; Rossi, A; Veltri, E	1
Anania, C; Casaretti, R; Comella, G; Comella, P; Curcio, C; Daponte, A; Maiorino, A; Musetta, G; Scoppa, G	1
Bisail, M; Farris, A; Intini, C; Sanna, G; Sarobba, MG; Scotto, T; Valzelli, S	1
Brancaccio, L; Comella, G; Curcio, C; D'Aprile, M; Gentile, M; Gridelli, C; Ianniello, GP; Maiorino, A; Palmeri, S; Pedicini, T	1
Feld, R	1
Anton, A; Gómez-Codina, J; Rosell, R; Sánchez, JJ; Vadell, C	1
Chasen, M; De Caro, L; Dhingra, H; Fossella, F; Komaki, R; Lee, JS; McGavran, M; Putnam, JB; Roth, JA; Ryan, MB	1
Antilli, A; Ardizzoni, A; Bruzzi, P; De Marinis, F; Mariani, GL; Pallotta, G; Pennucci, MC; Rosso, R; Rubagotti, A; Salvati, F	1
Funasako, M; Kobayashi, H; Nishio, K; Nishio, M; Ohata, M; Saijo, N; Sasaki, Y; Suruda, T; Uetani, K	1
Camaggi, CM; Carisi, P; Martoni, A; Melotti, B; Pannuti, F; Strocchi, E	1
Hirabayashi, M; Nagai, T; Nishikori, M; Okamura, A; Tatsumi, E; Yokoi, M	1
Chieco-Bianchi, L; Comis, S; Danova, M; Favaretto, A; Ghiotto, C; Giordano, M; Paccagnella, A; Panozzo, M; Pappagallo, G; Riccardi, A	1
Asada, S; Doi, H; Goto, H; Imaeda, T; Kanematsu, M; Matsui, E; Mochizuki, R; Shibayama, M; Yamawaki, Y	1
Kosaka, A; Sakaguchi, T; Watahiki, Y	1
Bakker, M; Groen, HJ; Postmus, PE; Riggi, M; Smeets, J; Smit, EF	1
Barrantes, JC; García, I; Lobo-Sanahuja, F; Santamaría, S	1
Bianco, AR; Bruni, GS; Gridelli, C; Incoronato, P; Rinaldi, L; Rossi, A; Ruffolo, P; Scognamiglio, F	1
Arriagada, R; Le Chevalier, T; Le Péchoux, C	1
Brancaccio, L; Carnicelli, P; Cioffi, R; Comella, P; De Cataldis, G; Ianniello, GP; Lombardi, A; Maiorino, A; Scarpati, MD; Tinessa, V	1
Andreyev, HJ; Cunningham, D; Hill, AS; Norman, AR; Padhani, AR; Ross, PJ; Webb, A	1
Curcio, C; D'Aprile, M; Gridelli, C; Ianniello, G; Lorusso, V; Palmeri, S; Palmieri, G; Perrone, F; Rossi, A; Veltri, E	1
Biganzoli, L; Caraci, P; Gebbia, V; Iirillo, A; Maiorino, L	1
Berchier, MC; Bureau, G; Giner, V; Klastersky, J; Kroll, F; Küstner, U; Lecomte, J; Michel, J; Mommen, P; Paesmans, M; Sculier, JP; Sergysels, R; Van Cutsem, O	1
Bonnefoi, H; Smith, IE	1
Charitopoulos, K; Dimitriadis, K; Economides, D; Maglaveras, N; Papagiannis, A; Vamvalis, C; Zarogoulidis, K; Ziogas, E	1
Bianco, AR; Curcio, C; D'Aprile, M; Gebbia, V; Gridelli, C; Palmeri, S; Pepe, R; Pistillucci, G; Rossi, A; Veltri, E	1
Cannata, G; Gebbia, N; Gebbia, V; Testa, A	1
Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R; Wenger, M	2
Du Bois, A; Hecker, D; Köhler, G; Lisboa, B; Lück, HJ; Thomssen, C; Untch, M	1
Bardonnet-Comte, M; Berthaud, P; Chomy, F; Chomy, P; Douillard, JY; Gautier, V; Lagrange, JL; Le Chevalier, T; Milleron, B; Polin, V; Pujol, JL; Quoix, E; Rivière, A; Spaeth, D	1
Evans, TR; Gogas, H; Lofts, FJ; Mansi, JL; Millard, FJ; Wilson, R	1
Adachi, I; Kanda, K; Murai, H; Ogita, M; Saeki, T; Sano, M; Sasaki, Y; Shimoyama, M; Tabei, T; Takashima, S; Watanabe, T	1
Cariello, S; Colucci, G; Galetta, D; Gebbia, N; Gebbia, V; Riccardi, F	1
Dziewulska-Bokiniec, A; Rolka-Stempniewicz, G; Wojtacki, J	1
Bacci, G; Bertoni, F; Briccoli, A; Campanacci, M; Cesari, M; Fabbri, N; Ferrari, S; Forni, C; Gasbarrini, A; Mercuri, M	1
Folga, A; Fryze, W; Jassem, E; Mincewicz, H; Olszewska, A; Słomiński, JM	1
Chen, YM; Lin, WC; Liu, JM; Perng, RP; Tsai, CM; Whang-Peng, J; Wu, HW; Wu, MF	1
Biesma, B; Cox, A; Festen, J; Postmus, PE; Splinter, TA; Tjan-Heijnen, VC; Wagener, DJ	1
Callegaro, D; Fantoni, U; Favaretto, A; Festi, G; Loy, M; Paccagnella, A; Rea, F; Sartori, F	1
Ambrosini, G; Busutti, L; Caffo, O; Farris, A; Ferrara, G; Guaraldi, M; Lelli, G; Martoni, A; Palomba, G; Pannuti, F; Petralia, A; Piana, E; Picece, V; Preti, P; Raimondi, M; Recaldin, E; Robustelli, G; Sarobba, G; Strocchi, E	1
Idezuki, Y; Ishizuka, N; Kobayashi, M; Murata, N; Suwata, J; Takada, S	1
Fountzilas, G; Kalofonos, C; Klouvas, G; Panoussaki, E; Pavlidis, N; Pectasides, D; Poulakis, N; Samantas, E; Skarlos, DV; Tsiakopoulos, E	1
Boher, JM; Daurès, JP; Grenier, J; Pujol, JL	1
Ardizzoia, A; Barni, S; Giani, L; Lissoni, P; Malugani, F; Mandalà, M; Paolorossi, F; Tancini, G	1
Bianco, A; Bilancia, D; Carpagnano, F; Cioffi, R; Comella, G; Comella, P; De Cataldis, G; De Lena, M; Di Rienzo, G; Frasci, G; Lorusso, V; Maiorino, L; Manzione, L; Natale, M; Nicolella, G; Pacilio, C; Panza, N	1
Drag-Zalesińska, M; Gebarowska, E; Wysocka, T; Zabel, M	1
Gebarowska, E; Kołodziej, J; Majewski, A; Zabel, M	1
Carmichael, J; Harris, AL; Mitchell, K; Philip, PA; Rea, D; Talbot, DC	1
Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R	2
Chang, WJ; Chen, CH; Liaw, CC; Tsao, TC; Yang, CT	1
Bosquée, L; Canon, JL; Humblet, Y; Rosier, JF; van de Velde, H; Weynants, P	1
Guaraldi, M; Martoni, A; Piana, E	1
Chen, YM; Lin, WC; Liu, JM; Perng, RP; Tsai, CM; Whang-Peng, J; Wu, HW; Yang, KY	1
Comte-Bardonnet, M; Daurès, JP; Khial, F; Marcillac, I; Oliver, P; Pujol, JL; Quantin, X; Rivière, A	1
Ceresoli, GL; Dell'Oro, S; Passoni, P; Villa, E	1
Dai, A; Feng, J; Zheng, X	1
Chen, Y; Lin, WC; Perng, RP; Tsai, CM; Whang-Peng, J; Wu, HW; Yang, KY	1
Attard, M; Failla, G; Ferraù, F; Gambino, L; Giuffrida, D; Janni, F; Marasà, L; Marletta, F; Restuccia, N	1
Davey, M; Davey, R; Locke, V	1
Herman, ZS; Machalski, M; Scieszka, M; Zielinski, M	1
Genvresse, I; Harder, H; Lange, C; Possinger, K; Schanz, J; Schweigert, M; Späth-Schwalbe, E	1
Dombernowsky, P; Hansen, HH; Hirsch, FR; Ingeberg, S; Jeppesen, N; Kristensen, C; Osterlind, K; Sorensen, PG	1
Ponarska, A; Rogala, E; Rogińska, E; Rowińska-Zakrzewska, E; Szopiński, J	1
Agelaki, S; Georgoulias, V; Kakolyris, S; Kalbakis, K; Kouroussis, C; Mavroudis, D; Palamidas, P; Raptis, A	1
Biesma, B; Giaccone, G; Huisman, C; Postmus, PE; Schramel, FM; Smit, EF	1
Canessa, P; Pronzato, P; Tognoni, A; Vaira, F; Vigani, A	1
Van Putten, JW	1
Yao, H; Zhou, J; Zhu, Q	1
Ikeda, T; Kitajima, M; Tokura, H	1
Chu, DT; Li, JL; Qu, FL; Sun, Y; Zhang, XR	1
Conte, PF; Dani, D; Donati, S; Gennari, A; Giorgetti, A; Landucci, E; Mariani, G; Pisani, P; Poli, M; Puccini, G; Salvadori, B; Salvadori, PA; Sorace, O	1
Bielawski, K; Falkiewicz, B; Granetzny, A; Klinke, F; Vogt, U; Zaczek, A	1
Bajetta, E; Beretta, E; Bombardieri, E; Buzzoni, R; Catena, L; Celio, L; Di Bartolomeo, M; Ferrari, L; Ferrario, E; Martinetti, A; Procopio, G; Seregni, E; Vitali, M	1
Bracarda, S; Crinò, L; Darwish, S; de Angelis, V; de Marinis, F; Latini, P; Maranzano, E; Meacci, L; Minotti, V; Panizza, BM; Piro, F; Tonato, M	1
Evans, WK; Feld, R; Gupta, S; Lassus, M; Shannon, P; Shepherd, FA; Walde, PL; Wierzbicki, R	1
Berendsen, HH; Piers, DA; Postmus, PE; Riva, A; Smeets, J; Smit, EF	1
Drozd-Lula, M; Jassem, J; Karnicka-Młodkowska, H; Kowal, E; Michalski, A; Moś-Antkowiak, R; Pilarska-Machowicz, A; Strug, A; Zych, J	1
Collard, P; Francis, C; Rodenstein, DO; Weynants, P	1
Airoma, G; Bianco, AR; Gridelli, C; Incoronato, P; Palazzolo, G; Pepe, R; Rossi, A	1
Abad, A; Barnadas, A; Carles, J; Haboubi, N; Jimeno, JM; Moreno, I; Ribelles, N; Rosell, R	1
Gatzemeier, U; Hossfeld, DK; Laumen, R; Lenaz, L; Neuhauss, R; Reck, M; von Pawel, J	1
Thongprasert, S	1
Jassem, J; Kánitz, E; Kaplan, E; Kolaric, K; Mechl, Z; Pawlicki, M; Ringwald, G; Rolski, J; Schoket, Z; Vukas, D	1
Cortes-Funes, H; Evrard, D; Giaccone, G; Jassem, J; Karnicka, H; Kirkpatrick, A; Quoix, EA; Roozendaal, KJ; van Zandwijk, N; Wiatr, E	1
Nyman, CR	1
Piers, DA; Postmus, PE; Smit, EF	1
Bamberga, M; Bamberga, P; Gritti, G; Michetti, G; Ori-Belometti, M; Sarti, E; Villa, R	1
Busutti, L; Casadio, M; Guaraldi, M; Martoni, A; Pannuti, F	1
Beltrami, V; Bianco, AR; Ferrante, G; Gentile, M; Gridelli, C; Iacobelli, S; Irtelli, L; Martino, T; Natoli, C; Rossi, A	1
Balli, M; Bonciarelli, G; Jirillo, A; Lonardi, F; Pavanato, G	1
Fujii, S	1
De Blasio, F; De Matteis, L; Giacummo, A; Giunta, A; Itri, F; Losardo, L; Maione, S; Palma, M	1
Biscottini, B; Cellerino, R; Fatati, G; Guidi, F; Isidori, P; Raspugli, M; Tummarello, D	1
Guaraldi, M; Martoni, A; Melotti, B; Pannuti, F	1
Angeletti, CA; Balbarini, A; Del Tacca, M; Macchiarini, P; Mariani, M; Mariotti, R; Mengozzi, G; Palagi, C; Petronio, AS; Squartini, F	1
Kajanti, M; Mattson, K; Niiranen, A; Pyrhönen, S	1
Kefford, R; Raghavan, D; Rosenthal, M; Stuart-Harris, R	1
Angeletti, CA; Basolo, F; Bruno, J; Hardin, M; Macchiarini, P	1
Guaraldi, M; Martoni, A; Melotti, B; Pacciarini, MA; Pannuti, F; Riva, A	1
Riva, A; Sala, L; Smeets, J; Utama, I; Wils, J	1
Bonardi, G; Calciati, A; Donadio, M; Giaccone, G; Iberti, V	1
Crismancich, F; De Giovanni, D; Foladore, S; Magri, MD; Morassut, S; Nicotra, M; Serra, C; Tommasi, M; Tuveri, G; Veronesi, A	1
Blackstein, M; Eisenhauer, EA; Wierzbicki, R; Yoshida, S	1
Eckhardt, S; Jassem, J; Jelic, S; Kánitz, E; Kolaric, K; Koza, I; Mechl, Z; Schoket, Z; Vukas, D; Vuletic, L	1
Eich, F; Emser, W; Sybrecht, GW	1
Drings, P; Kretzschmar, A	1
Angeletti, CA; Bevilacqua, G; Danesi, R; Del Tacca, M; Fazzi, P; Giuntini, C; Macchiarini, P; Marchetti, A; Mariani, M; Mariotti, R	1
Blotta, A; Boltri, B; Busutti, L; Casadio, M; Falcone, F; Giordani, S; Lelli, G; Pannuti, F; Ramini, R	1
Banham, SW; Bicknell, S; Henderson, AF; Hughes, J; Milroy, R; Monie, RD	1
Angeletti, CA; Chella, A; Macchiarini, P; Mengozzi, G; Riva, A; Silvano, G; Solfanelli, S	1
Hartlapp, J; Heidemann, E; Hossfeld, D; Kunz, S; Neeser, E; Possinger, K; Schumacher, K; Steinke, B; von Ingersleben, G; Waldmann, R	1
Koralewski, P; Pawlicki, M	1
Cardiff, RD; Gribble, M; Kohler, M; Medrano, V; Meyers, FJ; Mitchell, EP; Quadro, R; Shiffman, R; William, L	1
Cole, SP; Gerlach, JH; Mirski, SE	1
Fritze, D; Harjung, H; Katz, R; Kober, B	1
Balli, M; Bonciarelli, G; Demicheli, R; Jirillo, A; Lonardi, F	1
Adamo, V; Alafaci, E; Altavilla, G; Buemi, B; Caristi, N; Condemi, G; Toscano, G	1
Beauduin, M; Bosly, A; Delaunois, L; Duprez, P; Francis, C; Gailly, C; Humblet, Y; Machiels, J; Majois, F; Weynants, P	1
Arai, R; Fukuoka, M; Furuse, K; Kawahara, M; Kodama, N; Matsui, K; Negoro, S; Ryu, S; Takada, M; Yamamoto, M	1
Jakobsson, M; Järvinen, M; Liippo, K; Nikkanen, TA; Nordman, E; Ojala, A; Paloheimo, S	1
Smeets, J; Utama, I; Wils, J	1
Biscottini, B; Cellerino, R; Fatati, G; Guidi, F; Isidori, P; Porfiri, E; Raspugli, M; Tummarello, D	1
Cersosimo, RJ; Hong, WK	1
Brown, JK	1
Bülzebruck, H; Drings, P; Hruska, D; Manke, HG; Schuler, G	1
Arai, R; Fukuoka, M; Furuse, K; Hayashi, S; Kawahara, M; Kiyota, M; Kodama, N; Kubota, K; Tsuruta, M; Yamamoto, M	1
Casadio, M; Giordani, S; Giuliotti, C; Lelli, G; Martoni, A; Pannuti, F; Strocchi, E	1
Bishop, J; Brodie, G; Burns, W; Coates, A; Levi, J; Raghavan, D; Schwarz, M; Snyder, R; Tattersall, M; Thomson, D	1
Abad-Esteve, A; Fernandez, C; Monras, P; Moreno, I; Morera, J; Ribas-Mundo, M; Rosell, R; Ruiz, J	1
Canova, N; Casadio, M; Giordani, S; Giuliotti, C; Lelli, G; Martoni, A; Pannuti, F	1
Bona, X; Codes, M; Duque, A; Iglesias, L; Jimeno, J; Moreno Nogueira, J; Murillo, E; Romero, F	1
Bartalucci, S; Cinelli, P; De Leonardis, V; De Scalzi, M; Neri, B	1
Geran, R; Goldin, A; Venditti, JM	1

Reviews

11 review(s) available for epirubicin and Lung Neoplasms

Article	Year
Assessing the relative effectiveness and tolerability of treatments in small cell lung cancer: a network meta-analysis. Cancer epidemiology, 2013, Volume: 37, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Randomized Controlled Trials as Topic	2013
Leiomyosarcoma of the parotid gland in an HIV-positive patient: therapeutic approach, clinical course and review of the literature. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Biomarkers, Tumor; Bone Neoplasms; Combined Modality Therapy; Epirubicin; Fatal Outcome; Female; HIV Infections; Humans; Ifosfamide; Immunohistochemistry; Leiomyosarcoma; Lung Neoplasms; Lymphatic Metastasis; Parotid Neoplasms; Radiotherapy	2009
Cisplatin plus etoposide versus other platin-based regimens for patients with extensive small-cell lung cancer: a systematic review and meta-analysis of randomised, controlled trials. Internal medicine journal, 2012, Volume: 42, Issue:12 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cisplatin; Cost-Benefit Analysis; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Etoposide; Humans; Irinotecan; Lung Neoplasms; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Treatment Outcome	2012
Carboplatin-epirubicin regimen for the treatment of hepatoblastoma. Pediatric blood & cancer, 2004, Volume: 42, Issue:2 Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Epirubicin; Hepatoblastoma; Humans; Infant; Liver Neoplasms; Lung Neoplasms; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Prospective Studies; Survival Rate; Treatment Outcome	2004
Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials. Lung cancer (Amsterdam, Netherlands), 2006, Volume: 51, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Deoxycytidine; Epirubicin; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Paclitaxel; Randomized Controlled Trials as Topic; Survival Rate; Taxoids; Vinblastine; Vinorelbine	2006
High-dose or dose-intensive chemotherapy for non-small cell carcinoma of the lung. Seminars in oncology, 1994, Volume: 21, Issue:1 Suppl 1 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Humans; Lung Neoplasms	1994
Anthracyclines in non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2001, Volume: 34 Suppl 4 Topics: Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Epirubicin; Humans; Lung Neoplasms	2001
[Intra-arterial infusion chemotherapy for breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Mitomycin	2002
The treatment of advanced non-small-cell lung cancer (NSCLC)--overseas updated and local experiences. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Epirubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Survival Rate	2002
Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:3 Topics: Bone Marrow; Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Small Cell; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Head and Neck Neoplasms; Heart; Humans; Kidney Neoplasms; Kinetics; Leukemia; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Soft Tissue Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms	1986
The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review. Investigational new drugs, 1985, Volume: 3, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation, Preclinical; Epirubicin; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma; Neoplasm Transplantation; Neoplasms, Experimental	1985

Trials

117 trial(s) available for epirubicin and Lung Neoplasms

Article	Year
A multicenter phase I-II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancer. Breast (Edinburgh, Scotland), 2013, Volume: 22, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Anemia; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Diarrhea; Disease-Free Survival; Docetaxel; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplastic Cells, Circulating; Neutropenia; Receptor, ErbB-2; Survival Rate; Taxoids; Thrombocytopenia; Young Adult	2013
Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors. Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Retroperitoneal Neoplasms; Retrospective Studies; Stomach Neoplasms; Survival Rate; Young Adult	2015
Value of whole-tumor dual-input perfusion CT in predicting the effect of multiarterial infusion chemotherapy on advanced non-small cell lung cancer. AJR. American journal of roentgenology, 2014, Volume: 203, Issue:5 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Perfusion Imaging; Radiography, Thoracic; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2014
Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†. Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:5 Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Epirubicin; Etoposide; Female; France; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Small Cell Lung Carcinoma; Time Factors; Treatment Outcome; Young Adult	2015
[A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2016, Volume: 38, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Docetaxel; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Induction Chemotherapy; Lung Neoplasms; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Taxoids	2016
Phase I dose escalation study with irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients with solid malignancies. American journal of clinical oncology, 2008, Volume: 31, Issue:3 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Camptothecin; Capecitabine; Deoxycytidine; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Synergism; Epirubicin; Female; Fluorouracil; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Infusions, Intravenous; Irinotecan; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Topoisomerase II Inhibitors; Treatment Outcome	2008
Population-based phase I trial of irinotecan and epirubicin. American journal of clinical oncology, 2008, Volume: 31, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Camptothecin; Carcinoma, Non-Small-Cell Lung; Diarrhea; Drug Administration Schedule; Drug Synergism; Epirubicin; Female; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Irinotecan; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Topoisomerase I Inhibitors	2008
Retrospective study of efficacy and toxicity on patients older than 70 years within a randomized clinical trial of two cisplatin-based combinations in patients with small-cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2009, Volume: 63, Issue:1 Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Epirubicin; Etoposide; Humans; Lung Neoplasms; Middle Aged; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome	2009
Phase II study of epirubicin in combination with weekly docetaxel for patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based chemotherapy. American journal of clinical oncology, 2009, Volume: 32, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Docetaxel; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Salvage Therapy; Survival Rate; Taxoids; Treatment Failure	2009
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy. Breast cancer research and treatment, 2011, Volume: 128, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epirubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Paclitaxel; Survival Rate; Treatment Outcome; Young Adult	2011
Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: a phase II study. Asia-Pacific journal of clinical oncology, 2013, Volume: 9, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Urinary Bladder Neoplasms	2013
Efficacy of anthracyclines and paclitaxel as first line chemotherapy in patients with visceral metastases of breast cancer. Minerva medica, 2002, Volume: 93, Issue:4 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Paclitaxel; Peritoneal Neoplasms	2002
Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer. The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:9 Topics: Adult; Antineoplastic Agents; Carboplatin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiography; Thyroid Neoplasms; Thyrotropin; Thyroxine	2002
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Germany; Humans; Liver Neoplasms; Logistic Models; Lung Neoplasms; Middle Aged; Mitoxantrone; Neoplasm Staging; Probability; Proportional Hazards Models; Quality of Life; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric; Survival Analysis; Treatment Outcome	2002
Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Dec-15, Volume: 20, Issue:24 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Quality of Life; Remission Induction; Survival Rate; Vincristine	2002
Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer. Saudi medical journal, 2003, Volume: 24, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Saudi Arabia; Survival Rate; Vincristine	2003
Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:8 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Epirubicin; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Staging; Probability; Prospective Studies; Receptor, ErbB-2; Risk Assessment; Soft Tissue Neoplasms; Statistics, Nonparametric; Survival Rate; Trastuzumab; Treatment Outcome	2003
First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial. British journal of cancer, 2003, Oct-06, Volume: 89, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Epirubicin; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Quality of Life; Survival Rate; Treatment Outcome	2003
A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. Journal of thrombosis and haemostasis : JTH, 2004, Volume: 2, Issue:8 Topics: Adult; Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Dalteparin; Disease Progression; Disease-Free Survival; Epirubicin; Female; Heparin, Low-Molecular-Weight; Humans; Lung Neoplasms; Male; Middle Aged; Time Factors; Treatment Outcome; Vincristine	2004
Prospective randomized phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer. Clinical lung cancer, 2004, Volume: 6, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cranial Irradiation; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Erythrocyte Transfusion; Etoposide; Female; Hospitalization; Humans; Lung Neoplasms; Male; Middle Aged; Platelet Transfusion; Prospective Studies; Radiotherapy, Adjuvant	2004
Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen). Lung cancer (Amsterdam, Netherlands), 2005, Volume: 48, Issue:2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cross-Over Studies; Cyclophosphamide; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Health Status; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Palliative Care; Prognosis; Treatment Outcome; Vincristine	2005
Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy. Breast cancer research and treatment, 2005, Volume: 91, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cisplatin; Epirubicin; Female; Humans; Incidence; L-Lactate Dehydrogenase; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Prognosis; Prospective Studies; Receptors, Estrogen; Risk Factors; Vindesine	2005
Weekly dose-dense cisplatin-epirubicin-paclitaxel administration with granulocyte colony-stimulating factor support does not substantially improve prognosis in extensive disease small-cell lung cancer. A SICOG phase II study. Oncology, 2005, Volume: 68, Issue:2-3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prognosis; Survival Analysis; Treatment Outcome	2005
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and Paclitaxel as first-line treatment. Oncology, 2005, Volume: 68, Issue:4-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Survival Rate; Treatment Outcome	2005
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer. Breast cancer research and treatment, 2006, Volume: 95, Issue:1 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Docetaxel; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Receptor, ErbB-2; Taxoids; Trastuzumab	2006
Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Mar-01, Volume: 24, Issue:7 Topics: Adolescent; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brazil; Carboplatin; Chemotherapy, Adjuvant; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Limb Salvage; Lung Neoplasms; Male; Methotrexate; Multivariate Analysis; Orthopedic Procedures; Osteosarcoma; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Survival Analysis; Treatment Outcome	2006
Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II study. British journal of cancer, 2006, May-08, Volume: 94, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Paclitaxel; Treatment Outcome	2006
Phase I/II study of gemcitabine and epirubicine in stage IIIB-IV non small cell lung cancer. Frontiers in bioscience : a journal and virtual library, 2006, Sep-01, Volume: 11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Epirubicin; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Treatment Outcome	2006
Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease). British journal of cancer, 2006, Aug-21, Volume: 95, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Pneumonectomy; Survival Analysis	2006
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study. British journal of cancer, 2007, Apr-10, Volume: 96, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Colorectal Neoplasms; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prognosis; Survival Rate	2007
Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer. Acta oncologica (Stockholm, Sweden), 2007, Volume: 46, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Survival Analysis; Tegafur; Time Factors; Treatment Outcome; Uracil	2007
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jan-01, Volume: 26, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Quality of Life; Treatment Outcome	2008
Phase I/II pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer. Clinical breast cancer, 2007, Volume: 7, Issue:11 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Glutamates; Guanine; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Pemetrexed; Treatment Outcome	2007
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trial. Lung cancer (Amsterdam, Netherlands), 2008, Volume: 62, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; DNA Topoisomerases, Type II; DNA-Binding Proteins; Endonucleases; Epirubicin; Female; Gemcitabine; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Treatment Outcome	2008
Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood, 1994, Sep-01, Volume: 84, Issue:5 Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Blood Transfusion, Autologous; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasms; Predictive Value of Tests; Vincristine	1994
M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen. Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Kidney Neoplasms; Kidney Pelvis; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Recombinant Proteins; Tomography, X-Ray Computed; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine; World Health Organization	1994
Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer. Seminars in oncology, 1995, Volume: 22, Issue:1 Suppl 2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Survival Analysis	1995
Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vinorelbine	1993
Combination chemotherapy with cyclophosphamide, epirubicin and etoposide in small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 1994, Volume: 11, Issue:3-4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged	1994
Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised study. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vincristine	1994
Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party. Seminars in oncology, 1995, Volume: 22, Issue:1 Suppl 2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Survival Analysis	1995
Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer. Acta oncologica (Stockholm, Sweden), 1994, Volume: 33, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male	1994
[Efficacy of intrahepatic arterial chemotherapy to prevent recurrence of residual liver in metastatic liver cancer patients after hepatectomy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:13 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Epirubicin; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual	1994
[Neoadjuvant intra-arterial infusion chemotherapy for the treatment of locally advanced breast cancer with remote metastases]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:13 Topics: Aged; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Mastectomy, Radical; Middle Aged	1994
Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI). Lung cancer (Amsterdam, Netherlands), 1994, Volume: 11, Issue:1-2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Digestive System Diseases; Epirubicin; Etoposide; Humans; Kidney Diseases; Life Tables; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Survival Analysis	1994
Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer. Cancer, 1994, Oct-01, Volume: 74, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging	1994
Cisplatin-VP16 alternating with cyclophosphamide-epirubicin versus cyclophosphamide-epirubicin-vincristine in small cell lung cancer. Journal of chemotherapy (Florence, Italy), 1993, Volume: 5, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Rate; Vincristine	1993
Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate. Seminars in oncology, 1994, Volume: 21, Issue:1 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male	1994
A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Journal of the National Cancer Institute, 1994, May-04, Volume: 86, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Remission Induction; Statistics as Topic; Survival Analysis; Time Factors; Treatment Outcome	1994
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task Force. Cancer, 1993, Nov-15, Volume: 72, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Italy; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Remission Induction; Survival Rate; Thrombocytopenia	1993
Pharmacokinetic re-evaluation and phase I study of high dose epirubicin in advanced non-small cell lung cancer. Japanese journal of clinical oncology, 1993, Volume: 23, Issue:5 Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged	1993
Epirubicin metabolism and pharmacokinetics after conventional- and high-dose intravenous administration: a cross-over study. Cancer chemotherapy and pharmacology, 1993, Volume: 32, Issue:4 Topics: Adult; Data Interpretation, Statistical; Epirubicin; Female; Half-Life; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged	1993
Granulocyte-macrophage colony-stimulating factor increases dose intensity of chemotherapy in small cell lung cancer. Relationship between clinical results, peripheral blood cell modifications, and bone marrow kinetics. Cancer, 1993, Aug-01, Volume: 72, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cell Count; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Treatment Outcome	1993
Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV. British journal of cancer, 1995, Volume: 72, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Vinblastine; Vinorelbine	1995
Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancer. Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged	1996
Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: a multicenter randomized clinical trial. Cancer, 1996, Jul-01, Volume: 78, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Epirubicin; Female; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Vindesine	1996
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer. European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:13-14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Carmustine; Cyclophosphamide; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged	1995
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Europe; Female; Humans; Ifosfamide; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Remission Induction; Survival Rate; Vindesine	1996
Interferon alpha-2a and combined chemotherapy as first line treatment in SCLC patients: a randomized trial. Lung cancer (Amsterdam, Netherlands), 1996, Volume: 15, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Drug Synergism; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Remission Induction	1996
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer. American journal of clinical oncology, 1996, Volume: 19, Issue:6 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cause of Death; Dose-Response Relationship, Drug; Drug Tolerance; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Sepsis; Thrombocytopenia	1996
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Cardiovascular Diseases; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pneumonectomy; Remission Induction; Survival Analysis; Transplantation Conditioning; Treatment Outcome	1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Lung Neoplasms; Male; Middle Aged; Palliative Care; Pneumonectomy; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Treatment Outcome	1997
Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancer. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:4 Suppl 3 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Lung Neoplasms; Middle Aged; Paclitaxel; Pleural Neoplasms; Treatment Outcome; Ventricular Function, Left	1997
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Survival Analysis	1997
Outpatient treatment with epirubicin and oral etoposide in patients with small-cell lung cancer. British journal of cancer, 1997, Volume: 76, Issue:5 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Outpatients; Survival Rate	1997
A phase II study of high-dose epirubicin (EPI) plus cyclophosphamide (CPA) with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors: a trial of the Japan Clinical Oncology Group. Japanese journal of clinical oncology, 1997, Volume: 27, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neutropenia; Prospective Studies; Receptors, Estrogen; Recombinant Proteins; Survival Rate; Thrombocytopenia	1997
Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM). British journal of cancer, 1997, Volume: 76, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Drug Administration Schedule; Epirubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Vinblastine; Vinorelbine	1997
[Usefulness of CA 15-3 antigen determination for evaluation of response to second-line chemotherapy in patients with breast cancer: preliminary study]. Polskie Archiwum Medycyny Wewnetrznej, 1997, Volume: 97, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mucin-1; Remission Induction	1997
Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy. Journal of chemotherapy (Florence, Italy), 1998, Volume: 10, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Extremities; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis	1998
Ifosfamide-based chemotherapy for previously treated lung cancer patients. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1998, Volume: 61, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Epirubicin; Female; Fluorouracil; Humans; Ifosfamide; Leucovorin; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Salvage Therapy	1998
Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 1998, Volume: 22, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Humans; Italy; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Treatment Outcome; Vinblastine; Vinorelbine	1998
[CBDCA, etoposide and epirubicin high-dose combination chemotherapy supported by peripheral blood stem cell transplantation (PBSCT) in metastatic breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local	1999
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology Group. American journal of clinical oncology, 1999, Volume: 22, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cranial Irradiation; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Survival Analysis	1999
Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study. Journal of pineal research, 1999, Volume: 26, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Melatonin; Middle Aged; Platelet Count; Remission Induction; Thrombocytopenia; Time Factors; Treatment Outcome	1999
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Quality of Life; Vinblastine; Vindesine; Vinorelbine	1999
[Epirubicin containing regimens in advanced malignant tumors report of 516 cases. Epirubicin Collaborative Study Group]. Zhonghua nei ke za zhi, 1997, Volume: 36, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Epirubicin; Female; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Vincristine	1997
A pilot study of increasing dose intensity of epirubicin and ifosfamide in patients with small cell lung cancer by using recombinant granulocyte colony-stimulating factor. Clinical oncology (Royal College of Radiologists (Great Britain)), 1999, Volume: 11, Issue:2 Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cohort Studies; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pilot Projects; Prospective Studies; Recombinant Proteins; Treatment Outcome	1999
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary	1999
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 107 patients with non-small-cell lung cancer: a mature follow-up report. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Survival Rate	1999
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clini Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Nervous System Neoplasms; Neutropenia; Recurrence; Survival Rate; Thoracic Neoplasms; Thrombocytopenia; Treatment Outcome	1999
Anthracyclines in non-small-cell lung cancer: do they have a therapeutic role? Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10 Suppl 5 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Treatment Outcome; Vinblastine; Vinorelbine	1999
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer. American journal of clinical oncology, 2000, Volume: 23, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Analysis; Tamoxifen	2000
Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer: searching for the maximal tolerated dose. American journal of clinical oncology, 2000, Volume: 23, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Quality of Life; Treatment Outcome	2000
Phase II study of paclitaxel and epirubicin as first-line treatment in patients with metastatic nonsmall cell lung carcinoma. Cancer, 2000, Jul-01, Volume: 89, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Epirubicin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Treatment Outcome; Ventricular Fibrillation	2000
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy. Lung cancer (Amsterdam, Netherlands), 2000, Volume: 29, Issue:2 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Salvage Therapy; Survival Analysis; Taiwan; Tamoxifen; Treatment Outcome	2000
Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patients. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Mesna; Middle Aged; Prospective Studies; Survival Analysis; Teniposide; Treatment Outcome; Vincristine	2001
[The effect of small cell lung cancer extension on secretion of interleukin-2 (IL-2) and interferon gamma (IFM gamma) in whole blood culture stimulated with mitogens]. Pneumonologia i alergologia polska, 2001, Volume: 69, Issue:1-2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Etoposide; Female; Glucuronates; Humans; Ifosfamide; Interferon-gamma; Interleukin-2; Lung Neoplasms; Male; Middle Aged; Radiotherapy, Adjuvant; Remission Induction	2001
A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2001, Volume: 34, Issue:1 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Topotecan	2001
Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy. British journal of cancer, 2001, Nov-16, Volume: 85, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Epirubicin; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome	2001
Activity of the combination of high-dose epirubicin with gemcitabine in advanced non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2001, Volume: 34 Suppl 4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Epirubicin; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged	2001
Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease Progression; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Stomach Neoplasms; Survival Analysis; Treatment Outcome	2002
Long-term results of induction chemotherapy followed by concurrent chemotherapy and thoracic irradiation in limited small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 37, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival; Treatment Outcome; Vincristine	2002
Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Heart Diseases; Humans; Lung Neoplasms; Male; Middle Aged	1992
A phase II study of high dose epirubicin in unresectable non small cell lung cancer. British journal of cancer, 1992, Volume: 65, Issue:3 Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Epirubicin; Female; Hemoglobins; Humans; Infusions, Intravenous; Leukocyte Count; Leukopenia; Lung Neoplasms; Male; Middle Aged; Platelet Count; Ventricular Function, Left	1992
Combination chemotherapy with vincristine, epirubicin and cyclophosphamide in small cell lung carcinoma. Polish Lung Cancer Cooperative Group. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28, Issue:2-3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Vincristine	1992
Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer. Investigational new drugs, 1992, Volume: 10, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Etoposide; Feasibility Studies; Humans; Lung Neoplasms; Male; Middle Aged; Treatment Outcome	1992
Carboplatin/etoposide/vincristine therapy in small cell lung cancer. Oncology, 1992, Volume: 49 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Drug Evaluation; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Recurrence; Thrombocytopenia; Time Factors; Vincristine	1992
Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose 4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancer. Oncology, 1992, Volume: 49, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Survival Analysis	1992
Epirubicin in previously untreated patients with small cell lung cancer: a phase II study by the EORTC Lung Cancer Cooperative Group. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:10 Topics: Aged; Aged, 80 and over; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male	1992
Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:12 Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Epirubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia	1992
Cyclophosphamide, epirubicin, etoposide, cis platinum (CEVP) in combination with radiotherapy: evaluation of a protocol adopted for 6 years in 148 cases of small cell lung cancer. Tumori, 1992, Oct-31, Volume: 78, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis	1992
A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC). Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged	1992
A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Radiotherapy; Survival Rate	1991
Activity of high-dose epirubicin in advanced non-small cell lung cancer. European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:10 Topics: Adult; Aged; Alopecia; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Evaluation; Epirubicin; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Stroke Volume	1991
Epirubicin in patients with inoperable non-small cell lung cancer--a phase II study. Acta oncologica (Stockholm, Sweden), 1991, Volume: 30, Issue:7 Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged	1991
Adjuvant chemotherapy for T1-2NOMO small cell lung cancer: single-agent or combination chemotherapy? Cancer investigation, 1991, Volume: 9, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Heart Failure; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Vomiting	1991
4'-EPI-doxorubicin in advanced lung cancer. A phase II trial. Investigational new drugs, 1990, Volume: 8, Issue:4 Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Drug Evaluation; Drugs, Investigational; Epirubicin; Female; Heart Failure; Humans; Lung Neoplasms; Male; Middle Aged	1990
Epirubicin in the treatment of malignant mesothelioma: a phase II cooperative study. The North-Eastern Italian Oncology Group (GOCCNE)--Mesothelioma Committee. Tumori, 1991, Feb-28, Volume: 77, Issue:1 Topics: Aged; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged	1991
Epirubicin in extensive small-cell lung cancer: a phase II study in previously untreated patients: a National Cancer Institute of Canada Clinical Trials Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:3 Topics: Carcinoma, Small Cell; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Multicenter Studies as Topic	1990
Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG). Medical oncology and tumor pharmacotherapy, 1990, Volume: 7, Issue:1 Topics: Adult; Aged; Carcinoma, Small Cell; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic	1990
High dose epirubicin chemotherapy in untreated poorer prognosis small cell lung cancer. Respiratory medicine, 1990, Volume: 84, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Drug Administration Schedule; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; United Kingdom	1990
Phase II feasibility study of high dose epirubicin-based regimens for untreated patients with small-cell lung cancer. American journal of clinical oncology, 1990, Volume: 13, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction	1990
Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancer. Onkologie, 1990, Volume: 13, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitoxantrone; Quality of Life; Randomized Controlled Trials as Topic; Survival Rate	1990
Bleomycin, vincristine, mitomycin and cisplatin alternated with cyclophosphamide, 4'-epidoxorubicin and procarbazine in advanced non-small-cell lung cancer. Tumori, 1988, Oct-31, Volume: 74, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Procarbazine; Vincristine	1988
Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group. Medical oncology and tumor pharmacotherapy, 1989, Volume: 6, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Organoplatinum Compounds	1989
Non small cell lung cancer (NSCLC). A prospective randomized trial with alternating chemotherapy CEP/MEC' versus no treatment. European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prospective Studies; Random Allocation	1988
A randomized study comparing platinum, doxorubicin, and VP-16 with platinum, 4'-epidoxorubicin, and VP-16 in patients with non-small-cell lung cancer. American journal of clinical oncology, 1987, Volume: 10, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Podophyllotoxin; Random Allocation	1987

Other Studies

139 other study(ies) available for epirubicin and Lung Neoplasms

Article	Year
Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features. BMC medical imaging, 2022, 07-26, Volume: 22, Issue:1 Topics: Epirubicin; Humans; Ifosfamide; Lung Neoplasms; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed	2022
Development of new bioactive molecules to treat breast and lung cancer with natural myricetin and its derivatives: A computational and SAR approach. Frontiers in cellular and infection microbiology, 2022, Volume: 12 Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Biological Products; Carboplatin; Epirubicin; Flavonoids; Humans; Lung Neoplasms; Molecular Docking Simulation; Molecular Dynamics Simulation; Water	2022
The effects of epirubicin-loaded Boc-L-Diphenylalanine peptide nanoparticles on cytotoxicity, genotoxicity, oxidative stress, and apoptosis in non-small cell lung cancer cells. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2023, Volume: 175 Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dipeptides; DNA Damage; Epirubicin; Humans; Lung Neoplasms; Nanoparticles; Oxidative Stress	2023
Sphingolipid-Based Synergistic Interactions to Enhance Chemosensitivity in Lung Cancer Cells. Cells, 2023, Nov-08, Volume: 12, Issue:22 Topics: Ceramides; Cisplatin; Epirubicin; Humans; Kinetics; Lung Neoplasms; Paclitaxel; Sphingolipids	2023
RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply. Cancer science, 2020, Volume: 111, Issue:2 Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell-Penetrating Peptides; Diosgenin; Epirubicin; Gene Expression Regulation, Neoplastic; Humans; Liposomes; Lung Neoplasms; Male; Mice; Neovascularization, Pathologic; Rats; Xenograft Model Antitumor Assays	2020
Survival, Chemotherapy Treatments, and Health Care Utilization Among Patients with Advanced Small Cell Lung Cancer: An Observational Study. Advances in therapy, 2020, Volume: 37, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Medicare; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome; United States	2020
EpiCO (epirubicin, cyclophosphamide and vincristine) as treatment for extrapulmonary high-grade neuroendocrine neoplasms. Zeitschrift fur Gastroenterologie, 2020, Volume: 58, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Humans; Lung Neoplasms; Neuroendocrine Tumors; Prognosis; Retrospective Studies; Treatment Outcome; Vincristine	2020
Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis. Drug development and industrial pharmacy, 2020, Volume: 46, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Chick Embryo; Chorioallantoic Membrane; Cyclooctanes; Epirubicin; Female; Humans; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Polycyclic Compounds; Xenograft Model Antitumor Assays	2020
Successful Treatment of Therapy-related Acute Promyelocytic Leukemia with All-trans-retinoic acid Following Epirubicin for Hepatocellular Carcinoma and Docetaxel and Pembrolizumab Therapies for Lung Carcinoma: A Triple Malignancy Case. The Tokai journal of experimental and clinical medicine, 2020, Jul-20, Volume: 45, Issue:2 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Hepatocellular; Docetaxel; Epirubicin; Humans; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Treatment Outcome; Tretinoin	2020
Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells. Molecules (Basel, Switzerland), 2020, Sep-16, Volume: 25, Issue:18 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Carriers; Drug Liberation; Epirubicin; Humans; Hydrogen-Ion Concentration; Kinetics; Lung Neoplasms; Nanoparticles; Paclitaxel; Polylactic Acid-Polyglycolic Acid Copolymer	2020
Transformation of NSCLC to SCLC after 1st- and 3rd-generation EGFR-TKI resistance and response to EP regimen and erlotinib: 2 CARE-compliant case reports. Medicine, 2021, Mar-12, Volume: 100, Issue:10 Topics: Acrylamides; Adult; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Resistance, Neoplasm; Epirubicin; ErbB Receptors; Erlotinib Hydrochloride; Fatal Outcome; Female; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Protein Kinase Inhibitors; Small Cell Lung Carcinoma; Tomography, X-Ray Computed; Treatment Outcome	2021
Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease. The Journal of dermatology, 2017, Volume: 44, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Administration Schedule; Epirubicin; Genital Neoplasms, Male; Groin; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Paclitaxel; Paget Disease, Extramammary; Scrotum; Skin Neoplasms; Treatment Outcome	2017
Transcatheter Arterial Chemoembolization with Spherical Embolic Agent in Patients with Pulmonary or Mediastinal Metastases from Breast Cancer. Journal of vascular and interventional radiology : JVIR, 2017, Volume: 28, Issue:10 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Chemoembolization, Therapeutic; Epirubicin; Female; Fluorouracil; Humans; Lung Neoplasms; Microspheres; Middle Aged; Mitomycin; Survival Rate; Treatment Outcome	2017
Terfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversal. Pharmacological research, 2017, Volume: 124 Topics: A549 Cells; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Survival; Drug Resistance, Neoplasm; Epirubicin; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; Male; Mice, Inbred BALB C; Receptors, Notch; Terfenadine; Tumor Burden; Wound Healing	2017
Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer. International journal of nanomedicine, 2017, Volume: 12 Topics: Animals; Antibiotics, Antineoplastic; Antigens, CD; Cadherins; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Line, Tumor; Epirubicin; Humans; Liposomes; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Phosphatidylinositol 3-Kinases; Xenograft Model Antitumor Assays	2017
Overexpression of miR-4443 promotes the resistance of non-small cell lung cancer cells to epirubicin by targeting INPP4A and regulating the activation of JAK2/STAT3 pathway. Die Pharmazie, 2018, 07-01, Volume: 73, Issue:7 Topics: Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Epirubicin; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Janus Kinase 2; Lung Neoplasms; MicroRNAs; Phosphoric Monoester Hydrolases; STAT3 Transcription Factor	2018
The effect of ifosfamide, epirubicin, and recombinant human endostatin therapy on a cardiac angiosarcoma: A case report. Medicine, 2019, Volume: 98, Issue:17 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Endostatins; Epirubicin; Heart Neoplasms; Hemangiosarcoma; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recombinant Proteins	2019
Development of R Artificial cells, nanomedicine, and biotechnology, 2019, Volume: 47, Issue:1 Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Drug Liberation; Epirubicin; Humans; Lipid Bilayers; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Polyethylene Glycols; Xenograft Model Antitumor Assays	2019
Epirubicin loaded to pre-polymerized poly(butyl cyanoacrylate) nanoparticles: preparation and in vitro evaluation in human lung adenocarcinoma cells. Colloids and surfaces. B, Biointerfaces, 2013, Jul-01, Volume: 107 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Cell Line, Tumor; Chemistry, Pharmaceutical; Colloids; Drug Screening Assays, Antitumor; Enbucrilate; Endocytosis; Epirubicin; Humans; Light; Lung Neoplasms; Microscopy, Fluorescence; Nanoparticles; Particle Size; Polymerization; Scattering, Radiation; Static Electricity	2013
Drug embedded PVP coated magnetic nanoparticles for targeted killing of breast cancer cells. Technology in cancer research & treatment, 2013, Volume: 12, Issue:5 Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Coated Materials, Biocompatible; Drug Delivery Systems; Epirubicin; Female; Folic Acid; Humans; Leukemia; Lung Neoplasms; Magnetite Nanoparticles; Male; Pharmaceutic Aids; Povidone; Prostatic Neoplasms; Spectroscopy, Fourier Transform Infrared	2013
Extraction protocol and mass spectrometry method for quantification of doxorubicin released locally from prodrugs in tumor tissue. Journal of mass spectrometry : JMS, 2013, Volume: 48, Issue:7 Topics: Animals; Chromatography, High Pressure Liquid; Doxorubicin; Epirubicin; Female; Limit of Detection; Linear Models; Lung Neoplasms; Mice; Mice, Nude; Prodrugs; Tandem Mass Spectrometry; Tissue Distribution; Xenograft Model Antitumor Assays	2013
[Treatment and prognosis of 117 patients with advanced urothelial carcinoma of the bladder]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2014, Volume: 36, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Retrospective Studies; Survival Rate; Thrombocytopenia; Urinary Bladder Neoplasms; Urothelium	2014
Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases. Anti-cancer drugs, 2014, Volume: 25, Issue:10 Topics: Adult; Antineoplastic Agents; Axilla; Combined Modality Therapy; Dioxoles; Epirubicin; Fatal Outcome; Humans; Ifosfamide; Lung Neoplasms; Male; Niacinamide; Phenylurea Compounds; Sarcoma, Synovial; Sorafenib; Tetrahydroisoquinolines; Trabectedin	2014
TIGAR has a dual role in cancer cell survival through regulating apoptosis and autophagy. Cancer research, 2014, Sep-15, Volume: 74, Issue:18 Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Cell Line, Tumor; Cell Survival; Epirubicin; Female; Gene Knockdown Techniques; Hep G2 Cells; Heterografts; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Nude; Phosphoric Monoester Hydrolases; Transfection	2014
An on-chip small intestine-liver model for pharmacokinetic studies. Journal of laboratory automation, 2015, Volume: 20, Issue:3 Topics: Animals; Caco-2 Cells; Camptothecin; Computer Simulation; Cyclophosphamide; Drug Screening Assays, Antitumor; Epirubicin; Hep G2 Cells; Humans; Intestine, Small; Irinotecan; Lab-On-A-Chip Devices; Liver; Liver Neoplasms; Lung; Lung Neoplasms; Organ Culture Techniques; Stomach Neoplasms	2015
Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma. Oncotarget, 2016, 11-01, Volume: 7, Issue:44 Topics: Albumin-Bound Paclitaxel; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Breast; Carcinoma; Chemotherapy, Adjuvant; Circulating Tumor DNA; Cisplatin; Cyclophosphamide; Disease Progression; Drug Resistance, Neoplasm; Epirubicin; ErbB Receptors; Female; Hand-Foot Syndrome; High-Throughput Nucleotide Sequencing; Humans; Hypertension; Lung Neoplasms; Mastectomy, Modified Radical; Middle Aged; Mutation; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Pyridines; Receptors, Vascular Endothelial Growth Factor; Sequence Analysis, DNA; Thoracic Neoplasms; Treatment Failure; Triple Negative Breast Neoplasms	2016
Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases. International journal of radiation oncology, biology, physics, 2009, Jun-01, Volume: 74, Issue:2 Topics: Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Combined Modality Therapy; Epirubicin; Feasibility Studies; Female; Humans; Iodized Oil; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Survival Rate	2009
[Elderly patient with metastatic gallbladder cancer treated by cisplatin, epirubicin and continuous infusion 5-fluorouracil]. Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:13 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Epirubicin; Female; Fluorouracil; Gallbladder Neoplasms; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Time Factors; Tomography, X-Ray Computed	2008
Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Capecitabine; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Staging; Prognosis; Soft Tissue Neoplasms; Survival Rate; Taxoids; Treatment Outcome; Young Adult	2009
[A case of aggressive primary squamous cell carcinoma of the breast refractory to preoperative neoadjuvant chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:13 Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Squamous Cell; Cyclophosphamide; Epirubicin; Fatal Outcome; Female; Fluorouracil; Humans; Lung Neoplasms; Neoadjuvant Therapy; Organoplatinum Compounds; Paclitaxel; Vinblastine; Vinorelbine	2009
[Complete response to M-FAP chemotherapy for multiple lung metastases after segmental resection of urachal carcinoma : a case report]. Hinyokika kiyo. Acta urologica Japonica, 2010, Volume: 56, Issue:2 Topics: Adenocarcinoma; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Fluorouracil; Humans; Lung Neoplasms; Male; Methotrexate; Urachus; Urinary Bladder Neoplasms	2010
[Features of blood supply and results of transarterial infusion and embolization in spinal metastases]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:1 Topics: Adult; Aged; Antibiotics, Antineoplastic; Back Pain; Breast Neoplasms; Chemoembolization, Therapeutic; Combined Modality Therapy; Embolization, Therapeutic; Epirubicin; Female; Gelatin Sponge, Absorbable; Humans; Iodized Oil; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Remission Induction; Spinal Neoplasms	2010
Gemcitabine and epirubicin plasma concentration-related excretion in saliva in patients with non-small cell lung cancer. Therapeutic drug monitoring, 2010, Volume: 32, Issue:3 Topics: Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; Deoxycytidine; Epirubicin; Gemcitabine; Humans; Infusions, Intravenous; Lung Neoplasms; Saliva	2010
Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors. Clinical colorectal cancer, 2010, Volume: 9, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Retrospective Studies; Treatment Outcome	2010
Mestastatic gastric cancer from malignant fibrous histiocytoma. Revista espanola de enfermedades digestivas, 2011, Volume: 103, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Dioxoles; Docetaxel; Epirubicin; Fatal Outcome; Gemcitabine; Histiocytoma, Malignant Fibrous; Humans; Ifosfamide; Lung Neoplasms; Male; Soft Tissue Neoplasms; Spinal Neoplasms; Stomach Neoplasms; Taxoids; Tetrahydroisoquinolines; Thigh; Thoracic Vertebrae; Trabectedin	2011
Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients. Pathology oncology research : POR, 2011, Volume: 17, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; DNA Topoisomerases, Type II; DNA-Binding Proteins; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Prospective Studies; Real-Time Polymerase Chain Reaction; RNA, Messenger; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome; Vault Ribonucleoprotein Particles; Vincristine	2011
[Evaluation of the efficacy of bronchial arterial infusion chemotherapy for the treatment of central non-small cell lung cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Survival Rate	2011
Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients. Lung cancer (Amsterdam, Netherlands), 2012, Volume: 75, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Epirubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local	2012
Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy. Journal of cancer research and clinical oncology, 2012, Volume: 138, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cisplatin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Gene Frequency; Genotype; Haplotypes; Humans; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Small Cell Lung Carcinoma; Vincristine	2012
[Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Myelopoiesis; Radiation Pneumonitis; Radiotherapy, Conformal; Remission Induction; Small Cell Lung Carcinoma; Survival Rate	2012
Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy. European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:18 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; DNA Repair; DNA-Binding Proteins; DNA, Neoplasm; Endonucleases; Epirubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Proteins; Pilot Projects; Prognosis; Retrospective Studies; Single-Blind Method; Slovenia; Topotecan; Treatment Outcome; Vincristine	2012
Impact of chemotherapy on hypercalcemia in breast and lung cancer patients. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Calcium; Chi-Square Distribution; Cisplatin; Cyclophosphamide; Deoxycytidine; Diphosphonates; Docetaxel; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Hypercalcemia; Imidazoles; Linear Models; Logistic Models; Lung Neoplasms; Male; Middle Aged; Pamidronate; Parathyroid Hormone-Related Protein; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Taxoids; Young Adult; Zoledronic Acid	2012
Fixed erythrodysaesthesia plaque due to gemcitabine and epirubicin treatment. Acta dermato-venereologica, 2002, Volume: 82, Issue:2 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Drug Eruptions; Epirubicin; Erythema; Gemcitabine; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Paresthesia; Skin; Taxoids	2002
"The guard dies, it does not surrender!" progress in the management of small-cell lung cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Dec-15, Volume: 20, Issue:24 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Humans; Lung Neoplasms; Vincristine	2002
[Clinical efficacy of the combination chemotherapy of high-dose epirubicin in non-small cell lung cancer]. Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 2001, Aug-28, Volume: 26, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin	2001
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head & neck, 2003, Volume: 25, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blindness; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cytarabine; Epirubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Nasal Cavity; Necrosis; Neoplasm Recurrence, Local; Nose Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Salvage Therapy; Spinal Cord Neoplasms; Survival Analysis	2003
[A case of recurrent breast cancer with lung metastasis and overexpression of HER2 that responded to UFT and cyclophosphamide combination therapy after sequential treatments with epirubicin, taxanes, and trastuzumab]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:6 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Drug Combinations; Epirubicin; Female; Humans; Lung Neoplasms; Mastectomy, Segmental; Middle Aged; Receptor, ErbB-2; Taxoids; Tegafur; Trastuzumab; Uracil	2003
Unusual response to second-line single-agent gemcitabine in locally advanced primary leiomyosarcoma of the lung: a case report. Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:5 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistance, Neoplasm; Epirubicin; Gemcitabine; Humans; Ifosfamide; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged	2003
[Treatment effect of percutaneous vertebroplasty combined with interventional chemotherapy on vertebral metastases]. Ai zheng = Aizheng = Chinese journal of cancer, 2005, Volume: 24, Issue:4 Topics: Adult; Aged; Bone Cements; Breast Neoplasms; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Lumbar Vertebrae; Lung Neoplasms; Male; Methotrexate; Middle Aged; Orthopedic Procedures; Pain Measurement; Radiography, Interventional; Spinal Neoplasms; Thoracic Vertebrae	2005
[A case of recurrent breast cancer with multiple lung, adrenal, inferior vena cava tumor thrombus and bone metastases successfully treated with 5'-DFUR and hormonal therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:4 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Papillary; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Floxuridine; Follow-Up Studies; Humans; Leuprolide; Lung Neoplasms; Mastectomy, Radical; Neoplastic Cells, Circulating; Tamoxifen; Vena Cava, Inferior	2005
Efficacy of two different platinum- or anthracycline-containing chemotherapy regimens for the treatment of small cell lung cancer. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chi-Square Distribution; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Probability; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome	2005
[Chemotherapy in extended small-cell lung cancer. Retrospective analysis of two different series of patients treated with carboplatin and etoposide or ciclophosphamide-epidoxorubicin and etoposide]. Recenti progressi in medicina, 2005, Volume: 96, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Retrospective Studies	2005
[Experimental studies of anti-proliferative effects of marinesponge extracts S1 - S3 on human lung adenocarcinoma and hepatocarcinoma cells]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2005, Volume: 28, Issue:3 Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Epirubicin; Humans; Liver Neoplasms; Lung Neoplasms; Materia Medica; Porifera; Stomach Neoplasms	2005
Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP). Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2005, Volume: 59, Issue:10 Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Blood Cell Count; Cells, Cultured; Disease Models, Animal; Drug Therapy, Combination; Epirubicin; Female; Gamma Rays; Hematopoiesis; Injections, Intraperitoneal; Leukopenia; Lung Neoplasms; Macrophages, Peritoneal; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Propolis; Radiation-Protective Agents; Solubility; Time Factors	2005
Prognostic factors in pleuro-pulmonary blastoma. Pediatric blood & cancer, 2007, Volume: 48, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Pneumonectomy; Prognosis; Pulmonary Blastoma; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Second-Look Surgery; Treatment Outcome; Vincristine	2007
Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents. Oncology, 2006, Volume: 70, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cytoplasm; Deoxycytidine; Diphosphonates; DNA Fragmentation; Drug Antagonism; Drug Synergism; Epirubicin; Fatty Acids, Monounsaturated; Female; Fluvastatin; Gemcitabine; Humans; Imidazoles; Indoles; Lung Neoplasms; Male; Prostatic Neoplasms; Zoledronic Acid	2006
[Cytological aspects of therapeutic pathomorphism of lung squamous cell carcinoma during intratumor chemotherapy]. Klinicheskaia laboratornaia diagnostika, 2006, Issue:4 Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cytodiagnosis; Doxorubicin; Epirubicin; Humans; Injections, Intralesional; Lung Neoplasms; Middle Aged	2006
[Experimental study of hydroxycamptothecine and theprubicine in the treatment of adenoid cystic carcinoma lung metastases]. Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology, 2006, Volume: 41, Issue:5 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Adenoid Cystic; Epirubicin; Female; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Salivary Gland Neoplasms; Tumor Cells, Cultured	2006
[Blood supply of pulmonary metastases and its clinical significance]. Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Camptothecin; Chemoembolization, Therapeutic; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Radiography; Remission Induction; Stomach Neoplasms; Young Adult	2006
[Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiation Dosage; Radiotherapy, Conformal; Survival Rate	2006
Multiple cutaneous metastases from male breast carcinoma. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Epirubicin; Fatal Outcome; Fluorouracil; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mastectomy, Radical; Megestrol Acetate; Middle Aged; Paclitaxel; Palliative Care; Skin Neoplasms	2006
[Prolonged hypoxia induces GST-pi expression and drug resistance in lung adenocarcinoma cell line SPCA1]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2007, Volume: 30, Issue:2 Topics: Adenocarcinoma; Cell Hypoxia; Cell Line, Tumor; Drug Resistance, Neoplasm; Epirubicin; Glutathione S-Transferase pi; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mitomycin; Plasmids; Transfection	2007
Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells. Molecular nutrition & food research, 2007, Volume: 51, Issue:8 Topics: Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; DNA Topoisomerases, Type II; DNA-Binding Proteins; Down-Regulation; Drug Synergism; Epirubicin; fas Receptor; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Lung Neoplasms; Poly-ADP-Ribose Binding Proteins; RNA, Messenger; Solanaceous Alkaloids; Up-Regulation	2007
Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel following mobilization with epirubicin and cisplatin are feasible but ineffective in treating patients with advanced non-small cell lung cancer. Bone marrow transplantation, 2007, Volume: 40, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leukapheresis; Lung Neoplasms; Middle Aged; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Recombinant Proteins	2007
Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breast. Journal of cutaneous pathology, 2007, Volume: 34, Issue:12 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Cyclophosphamide; Diphosphonates; Eccrine Glands; Epirubicin; Fluorouracil; Humans; Ibandronic Acid; Immunohistochemistry; Lung Neoplasms; Lymphatic Metastasis; Male; Radiotherapy; Sweat Gland Neoplasms; Tamoxifen; Tomography, X-Ray Computed	2007
Solamargine enhances HER2 expression and increases the susceptibility of human lung cancer H661 and H69 cells to trastuzumab and epirubicin. Chemical research in toxicology, 2008, Volume: 21, Issue:2 Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Combinations; Drug Screening Assays, Antitumor; Drug Synergism; Epirubicin; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Lung Neoplasms; Poly-ADP-Ribose Binding Proteins; Solanaceous Alkaloids; Trastuzumab; Up-Regulation	2008
Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung. European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:4 Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Doxorubicin; Drug Evaluation; Epirubicin; Humans; Lung Neoplasms; Time Factors	1984
Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer. Cancer treatment reports, 1983, Volume: 67, Issue:6 Topics: Adult; Aged; Doxorubicin; Drug Evaluation; Epirubicin; Humans; Leukocyte Count; Leukopenia; Lung Neoplasms; Middle Aged	1983
A phase II study of 4'-epi-doxorubicin plus cis-platinum in advanced solid tumors. European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:1 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Evaluation; Epirubicin; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms	1984
4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumors. Journal of cancer research and clinical oncology, 1984, Volume: 107, Issue:1 Topics: Adult; Aged; Alopecia; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Kidney Neoplasms; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Testicular Neoplasms; Thrombocytopenia	1984
[A phase I trial of 4'-epiadriamycin]. Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:4 Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Stomach Neoplasms; Thrombocytopenia	1984
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 1993, Volume: 10, Issue:3-4 Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; CD57 Antigens; Cell Differentiation; Chromogranin A; Chromogranins; Cisplatin; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Immunologic Factors; Interferons; Karnofsky Performance Status; Life Tables; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Proteins; Neoplasm Staging; Phosphopyruvate Hydratase; Prognosis; Proportional Hazards Models; Remission Induction; Retrospective Studies; Survival Rate; Synaptophysin; Vindesine	1993
[Intra-arterial infusion chemotherapy for advanced liver metastases from lung cancer via implantable vascular access: report of six cases]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:11 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin	1995
[Efficacy of treatment with frequent and low-dose epirubicin in two cases of pulmonary metastases after surgery of liver cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:12 Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged	1995
Interaction of the antiemetics ondansetron and granisetron with the cytotoxicity induced by irradiation, epirubicin, bleomycin, estramustine, and cisplatin in vitro. Acta oncologica (Stockholm, Sweden), 1995, Volume: 34, Issue:6 Topics: Animals; Antibiotics, Antineoplastic; Antiemetics; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bleomycin; Cells, Cultured; Cisplatin; Cricetinae; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Epirubicin; Estramustine; Fibroblasts; Granisetron; Humans; Lung Neoplasms; Ondansetron; Serotonin Antagonists; Tumor Cells, Cultured	1995
[Effectiveness of transthoracic puncture in the diagnosis and treatment of neoplasms of chest organs]. Voprosy onkologii, 1994, Volume: 40, Issue:1-3 Topics: Adenocarcinoma; Adolescent; Aged; Biopsy, Needle; Carcinoma, Squamous Cell; Doxorubicin; Epirubicin; Evaluation Studies as Topic; Female; Humans; Lung; Lung Neoplasms; Male; Mediastinal Neoplasms; Mediastinum; Middle Aged; Pneumonectomy; Radiography	1994
[Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis]. Minerva chirurgica, 1994, Volume: 49, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Catheterization; Drainage; Epirubicin; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Pleural Effusion, Malignant; Pleural Neoplasms; Pleurodesis; Propionibacterium acnes	1994
[Complete response of lung metastasis from bladder cancer by combination chemotherapy with methotrexate, epirubicin and cisplatin: a case report]. Hinyokika kiyo. Acta urologica Japonica, 1995, Volume: 41, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Epirubicin; Humans; Lung Neoplasms; Male; Methotrexate; Remission Induction; Urinary Bladder Neoplasms	1995
Metoclopramide inhibits the cytotoxicity of cisplatin and enhances the cytotoxicity of epirubicin. Pharmacology & toxicology, 1995, Volume: 76, Issue:2 Topics: Animals; Cell Line; Cell Survival; Cells, Cultured; Cisplatin; Cricetinae; Drug Synergism; Epirubicin; Fibroblasts; Humans; Lung Neoplasms; Metoclopramide; Tumor Cells, Cultured	1995
Uterine myxoid leiomyosarcoma and CYVADIC-etoposide therapy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1994, Volume: 46, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Epirubicin; Etoposide; Fatal Outcome; Female; Humans; Hysterectomy; Immunohistochemistry; Leiomyosarcoma; Lung Neoplasms; Mitotic Index; Treatment Outcome; Uterine Neoplasms; Vincristine	1994
Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC). Lung cancer (Amsterdam, Netherlands), 1993, Volume: 10, Issue:1-2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Epirubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Survival Rate	1993
Consolidative thoracic radiotherapy and prophylactic cranial irradiation in limited disease small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 1993, Volume: 10, Issue:3-4 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Lomustine; Lung Neoplasms; Methotrexate; Remission Induction; Survival Analysis; Thorax; Treatment Outcome; Vincristine	1993
Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancer. American journal of clinical oncology, 1994, Volume: 17, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate	1994
[Malignant lymphoma following operation and chemotherapy of small cell lung carcinoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Pneumonectomy; Prednisolone; Remission Induction; Vincristine	1993
[Superselective bronchial arterial infusion therapy with cisplatin and epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hilar lung adenocarcinoma: preliminary clinical experience]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1993, Sep-25, Volume: 53, Issue:9 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Cisplatin; Epirubicin; Humans; Infusions, Intra-Arterial; Iodized Oil; Iohexol; Lung Neoplasms; Male; Mitomycins	1993
[A case of breast cancer with thrombosis during treatment of lung metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:4 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intravenous; Lentinan; Lung Neoplasms; Medroxyprogesterone Acetate; Pulmonary Embolism; Radiography; Tamoxifen; Tegafur; Thrombophlebitis; Uracil	1993
Case report: pulmonary blastoma in children--response to chemotherapy. Medical and pediatric oncology, 1996, Volume: 26, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Pulmonary Blastoma; Vincristine	1996
Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer. Cancer, 1995, Aug-01, Volume: 76, Issue:3 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Humans; Lung Neoplasms	1995
Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF). European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:13-14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiography; Remission Induction; Survival Analysis	1995
Thyroid cancer: different outcomes to chemotherapy according to tumour histology. European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:13-14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Thyroid Neoplasms; Treatment Outcome	1995
How should cancer presenting as a malignant pleural effusion be managed? British journal of cancer, 1996, Volume: 74, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carcinoma; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasms, Unknown Primary; Palliative Care; Pleural Effusion, Malignant; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine	1996
Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study. Anti-cancer drugs, 1996, Volume: 7, Issue:7 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Epirubicin; Female; Humans; Lung Neoplasms; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Ovarian Neoplasms; Pilot Projects; Prednisolone; Uterine Neoplasms; Vinblastine; Vinorelbine; Vomiting	1996
[A case of binocular blindness in small cell lung cancer]. Pneumonologia i alergologia polska, 1998, Volume: 66, Issue:1-2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blindness; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Fatal Outcome; Humans; Lung Neoplasms; Male; Paraneoplastic Syndromes	1998
Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Mesna; Prospective Studies; Recombinant Proteins; Vincristine	1998
Long term results of surgery and chemotherapy in small cell lung cancer. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 1998, Volume: 14, Issue:4 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Longitudinal Studies; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Postoperative Complications; Prospective Studies; Radiotherapy, Adjuvant; Survival Rate; Vincristine	1998
Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis. British journal of cancer, 1999, Volume: 79, Issue:9-10 Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Humans; Keratin-19; Keratins; Lung Neoplasms; Markov Chains; Prognosis; Proportional Hazards Models; Prospective Studies; Tissue Polypeptide Antigen	1999
Evaluation of apoptosis and necrosis induction in cultured cells of lung carcinomas under effect of cytostatic drugs in vitro. Folia histochemica et cytobiologica, 1999, Volume: 37, Issue:2 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Bleomycin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Etoposide; Humans; Lung Neoplasms; Methotrexate; Necrosis; Tumor Cells, Cultured; Vinblastine; Vincristine	1999
Evaluation of individual sensitivity to cytostatic drugs of in vitro cultured lung tumor cells. Folia histochemica et cytobiologica, 1999, Volume: 37, Issue:2 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bleomycin; Carcinoma, Non-Small-Cell Lung; Cell Division; Cisplatin; Epirubicin; Etoposide; Fluorouracil; Lung Neoplasms; Methotrexate; Tumor Cells, Cultured; Vinblastine; Vincristine	1999
The effects of two different cisplatin-based chemotherapy regimens on advanced non-small cell lung cancer. Changgeng yi xue za zhi, 1999, Volume: 22, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Mitomycin; Retrospective Studies; Survival Rate	1999
[A clinical report of high-dose epirubicin combined with cyclophosphamide and fluorouracil for advanced breast cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 1998, Volume: 20, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Medullary; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging	1998
Thyroid carcinosarcoma, a rare and aggressive histotype: a case report. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:11 Topics: Antibiotics, Antineoplastic; Carcinosarcoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Epirubicin; Fatal Outcome; Female; Humans; Lung Neoplasms; Lymph Node Excision; Middle Aged; Radiotherapy, Adjuvant; Thyroid Neoplasms; Thyroidectomy	2000
Paclitaxel sensitization of multidrug-resistant cells to chemotherapy is independent of the cell cycle. Cytometry, 2001, Mar-01, Volume: 43, Issue:3 Topics: Amsacrine; Antineoplastic Agents; Camptothecin; Carcinoma, Small Cell; Cell Cycle; Cell Survival; Chlorambucil; Cisplatin; Daunorubicin; Drug Resistance, Multiple; Epirubicin; Genistein; Humans; Lung Neoplasms; Paclitaxel; Tumor Cells, Cultured; Vinblastine; Vinorelbine	2001
Quality of life in cancer patients treated by chemotherapy. Neoplasma, 2000, Volume: 47, Issue:6 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Colorectal Neoplasms; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Neoplasms; Quality of Life; Stomach Neoplasms; Surveys and Questionnaires	2000
Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study. Anti-cancer drugs, 2001, Volume: 12, Issue:4 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amifostine; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Deoxycytidine; Doxorubicin; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Gemcitabine; Humans; Hypertension; Hypocalcemia; Hypotension; Infusions, Intravenous; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Paclitaxel; Pancreatic Neoplasms; Platinum; Prednisone; Premedication; Retrospective Studies; Vincristine	2001
[Chemotherapy of non-small-cell lung cancer (NSCLC) and changes in serum sAPO-1/Fas and nitric oxide (NO) levels]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2000, Volume: 22, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; fas Receptor; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitric Oxide; Teniposide; Treatment Outcome	2000
Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients. Clinical breast cancer, 2000, Volume: 1, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Drug Monitoring; Epirubicin; Female; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Humans; Liver Neoplasms; Lung Neoplasms; Paclitaxel; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Soft Tissue Neoplasms; Survival Analysis; Time Factors; Tomography, Emission-Computed; Treatment Outcome	2000
p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer. Journal of cancer research and clinical oncology, 2002, Volume: 128, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; DNA Mutational Analysis; DNA, Complementary; DNA, Neoplasm; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Genes, p53; Humans; Lung Neoplasms; Male; Middle Aged; Polymerase Chain Reaction; Prognosis; Tumor Cells, Cultured	2002
Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin. Thorax, 1992, Volume: 47, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Tomography, X-Ray Computed	1992
Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer. Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Vindesine	1992
Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:8 Suppl Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate; Vinblastine	1992
Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy with carboplatin, etoposide and epirubicin. Thorax, 1992, Volume: 47, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Epirubicin; Etoposide; Humans; Lung Neoplasms	1992
Neoadjuvant chemotherapy with cisplatin, epirubicin and VP-16 for stage IIIA-IIIB non-small-cell lung cancer: a pilot study. Tumori, 1992, Dec-31, Volume: 78, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Treatment Outcome	1992
The role of three cisplatin-based chemotherapy regimens in the treatment of advanced non-small cell lung cancer. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Retrospective Studies; Vincristine; Vindesine	1992
[Successful treatment of adenocarcinoma of the lung with bone metastases by combined chemotherapy with epirubicin, mitomycin C and carboplatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:12 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Epirubicin; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin	1992
Left ventricular diastolic function with epirubicin therapy: an echodoppler study. International journal of clinical pharmacology, therapy, and toxicology, 1992, Volume: 30, Issue:6 Topics: Adult; Aged; Blood Pressure; Diastole; Echocardiography; Echocardiography, Doppler; Epirubicin; Female; Heart Rate; Humans; Lung Neoplasms; Male; Middle Aged; Stroke Volume; Ventricular Function, Left	1992
[The evaluation of the cardiotoxicity of 4'-epidoxorubicin at high doses]. Cardiologia (Rome, Italy), 1991, Volume: 36, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Echocardiography; Epirubicin; Etoposide; Female; Heart; Humans; Lung Neoplasms; Male; Middle Aged; Myocardium	1991
Epirubicin: a phase II study in recurrent small-cell lung cancer. Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:3 Topics: Aged; Carcinoma, Small Cell; Drug Evaluation; Epirubicin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Remission Induction; Time Factors	1991
High-dose epirubicin for untreated patients with advanced tumours: a phase I study. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:11-12 Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms	1990
Phase II study of high-dose epirubicin in non-small cell lung cancer. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:11-12 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged	1990
[Nerve conduction velocity following high-dose vincristine in the treatment of small cell bronchial cancer]. Pneumologie (Stuttgart, Germany), 1990, Volume: 44 Suppl 1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Reaction Time; Synaptic Transmission; Vincristine	1990
Epirubicin weekly in combination chemotherapy with cyclophosphamide and vincristine in untreated small cell lung cancer: a phase II trial. Onkologie, 1990, Volume: 13, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Vincristine	1990
Phase II study of high-dose epirubicin in untreated patients with small-cell lung cancer. American journal of clinical oncology, 1990, Volume: 13, Issue:4 Topics: Aged; Carcinoma, Small Cell; Drug Evaluation; Echocardiography; Electrocardiography; Epirubicin; Female; Follow-Up Studies; Heart; Humans; Lung Neoplasms; Male; Middle Aged; Myocardium; Remission Induction; Survival Rate	1990
Small cell bronchogenic carcinoma: a cyclical alternating combination of epirubicin plus cisplatin and cyclophosphamide plus etoposide. Journal of chemotherapy (Florence, Italy), 1990, Volume: 2, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged	1990
[Possibility of 4'-epiadriamycin treatment of patients with malignant neoplasms and coexistent heart diseases with implanted pacemaker]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 1990, Apr-01, Volume: 43, Issue:7 Topics: Aged; Arrhythmias, Cardiac; Breast Neoplasms; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pacemaker, Artificial; Remission Induction; Time Factors	1990
Epirubicin in non-oat cell lung cancer--response rates and the importance of immunopathology: a Northern California Oncology Group Study. Cancer treatment reports, 1986, Volume: 70, Issue:6 Topics: Adult; Aged; Doxorubicin; Epirubicin; Female; Heart Diseases; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Staining and Labeling; Statistics as Topic; Stereoisomerism	1986
Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer research, 1987, May-15, Volume: 47, Issue:10 Topics: Animals; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cell Line; Colchicine; Daunorubicin; Doxorubicin; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Epirubicin; Etoposide; Glycoproteins; Gramicidin; Humans; Immunosorbent Techniques; Isoxazoles; Lung Neoplasms; Menogaril; Mice; Mice, Inbred BALB C; Mitoxantrone; Nogalamycin; Phenotype; Vinblastine; Vincristine	1987
[Results of palliative chemotherapy in advanced small cell bronchial carcinoma]. Deutsche medizinische Wochenschrift (1946), 1988, Oct-28, Volume: 113, Issue:43 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Palliative Care; Prognosis; Retrospective Studies; Vincristine	1988
VP16, epirubicin and procarbazine in the treatment of advanced non-small-cell lung cancer. Tumori, 1989, Apr-30, Volume: 75, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Procarbazine	1989
[Phase II studies of a single agent and a cis-platinum-based two-drug combination in patients with non-small cell lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis	1988
Doxorubicin and 4'-epidoxorubicin in combination chemotherapy of extensive small cell lung cancer. Acta oncologica (Stockholm, Sweden), 1988, Volume: 27, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vincristine	1988
Chemotherapy consisting of epirubicin, cisplatin, and etoposide followed by irradiation in stage III non-small cell lung cancer and chemotherapy alone in stage IV non-small cell lung cancer. Oncology, 1988, Volume: 45, Issue:6 Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging	1988
Protocol cost analysis. Progress in clinical and biological research, 1986, Volume: 216 Topics: Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cost Control; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Epirubicin; Fees, Medical; Humans; Lung Neoplasms; Medicare; Vincristine	1986
[EPICO in the treatment of small cell bronchial cancer. 3. Intermediate analysis]. Onkologie, 1986, Volume: 9 Suppl 1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Vincristine	1986
[A phase II study of epirubicin in advanced lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:9 Topics: Adenocarcinoma; Aged; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea	1986
Phase II studies on weekly cisplatinum plus epirubicin or etoposide in the treatment of advanced non-small cell bronchogenic carcinoma. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged	1986
Phase I study of epirubicin given on a weekly schedule. Cancer treatment reports, 1987, Volume: 71, Issue:3 Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Small Cell; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Heart Diseases; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged	1987
4'-Epidoxorubicin plus cisplatin as first-line therapy in the treatment of small cell bronchogenic carcinoma. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Topics: Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Epirubicin; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged	1987
Epirubicin in rectal cancer. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:3 Topics: Adult; Aged; Drug Evaluation; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Rectal Neoplasms; Stereoisomerism	1988
Echocardiographic assessment of anthracycline cardiotoxicity during different therapeutic regimens. International journal of clinical pharmacology research, 1987, Volume: 7, Issue:4 Topics: Adult; Breast Neoplasms; Carnitine; Doxorubicin; Echocardiography; Epirubicin; Female; Heart Diseases; Humans; Lung Neoplasms; Male; Middle Aged	1987